Blog

Roundup Lawsuit
July 25, 2018 Categories: Product Liability, Settlements and Lawsuits

Non-Hodgkin lymphoma patient who was working with Roundup is suing Monsanto

It has been a few years since Roundup®, a product of Monsanto, was reportedly linked to a serious disease called non-Hodgkin lymphoma. People who worked with the weed-killer Roundup® across the United States were exposed to glyphosate, which is the main ingredient in the most popular herbicide in the country. Case of DeWayne Johnson against...

more →
Gadolinium Poisoning MRI
July 18, 2018 Categories: FDA updates, Product Liability

Gadolinium MRI Poisoning Investigation

The FDA issued a safety alert in December 2017, stating that some patients who received a gadolinium-based contrast during an MRI procedure, may retain the gadolinium in their bodies for months, or even for years, causing serious side effects. Gadolinium is commonly used in MRIs to enhance the images the test provides. Gadolinium is a...

more →
Valsartan recall
July 17, 2018 Categories: Dangerous Drugs, FDA updates

FDA recalls Valsartan – Antihypertensive drug

Valsartan is mainly used for treatment of high blood pressure, congestive heart failure, and after a heart attack. The FDA has announced a recall of several drugs that contain the heart drug valsartan because a possible carcinogen NDMA (N-Nitrosodimethylamine) that was found in the recalled products. NDMA, which was found in the valsartan products, could...

more →
talcum powder cancer
July 16, 2018 Categories: Product Liability, Settlements and Lawsuits

Jury Finds Ovarian Cancer caused by Talcum Powder

Johnson & Johnson must pay $4.14 billion in punitive damages after a jury found that plaintiffs’ ovarian cancers were caused by asbestos in Johnson & Johnson’s talcum powder products. Popular products like Shower-to-Shower, and “Johnson’s Baby Powder” have been linked to ovarian cancer after regular use. 22 plaintiffs were awarded $25 million each. Johnson &...

more →
FLQ linked to Mental Health Side Effects
July 12, 2018 Categories: Dangerous Drugs, FDA updates

Fluoroquinolone Antibiotics are linked to Mental Health Side Effects

FDA posted a label changes request for FLQ on July 10th of 2018. FLQs such as Levaquin, Cipro, Avelox and others can cause the following side effects: disturbances in attention disorientation agitation nervousness memory impairment serious disturbances in mental abilities called delirium. “FDA is strengthening the current warnings in the prescribing information that fluoroquinolone antibiotics...

more →
roundup lawsuit
June 18, 2018 Categories: Product Liability, Settlements and Lawsuits

First Monsanto Roundup® case will go to trial next week

Lee Johnson, 46-year-old groundskeeper for the school district in Benicia, California, was diagnosed with cancer in 2014 after years of working with Roundup ® weed-killer. Johnson will be the first among thousands of people across the U.S. to go to trial against Monsanto, blaming Roundup ® herbicide for their disease. Now, a jury will decide...

more →
FDA Now Regulates E-Cigarettes and Vaporizers
May 24, 2018 Categories: FDA updates

FDA Now Regulates E-Cigarettes and Vaporizers

FDA’s Deeming Regulations for E-Cigarettes, Cigars, and All Other Tobacco Products. Mitch Zeller, Director of FDA’s Center for Tobacco Products posted in his blog that It will become illegal nationwide to sell cigars, hookah tobacco, and e-cigarettes to anyone under age 18 and retailers will need to check photo ID of anyone under age 27....

more →
parkinson
April 10, 2018 Categories: Dangerous Drugs

Parkinson’s Disease Treatment Drug Reports Deaths Spark

A new medication called Nuplazid, made by San Diego-based Acadia Pharmaceuticals had been designated a “breakthrough therapy” – meaning that it demonstrated “substantial improvement” in patients with serious or life-threatening diseases compared to treatments already on the market. The physician who led the FDA’s medical review, Dr. Paul Andreason, warned that patients taking the drug...

more →
Essure
April 9, 2018 Categories: Defective Medical Devices

FDA restricts sale and distribution of Essure

As of today, FDA restricts sale and distribution of Essure to protect women and to require that patients receive risk information. “The U.S. Food and Drug Administration today issued an order to restrict the sale and distribution of the Essure device to ensure that all women considering use of the permanent contraception device are provided...

more →
Zenith Alpha Thoracic Endovascular Graft
August 28, 2017 Categories: Defective Medical Devices

Endovascular device recalled by the FDA

The FDA issued a safety alert for Zenith Alpha Thoracic Endovascular Graft – a device for the endovascular treatment of patients with aneurysms. Class I Recall – Potential Formation of Thrombus Inside Device.

more →
Recent Updates

It has been a few years since Roundup®, a product of Monsanto, was reportedly linked to a serious disease called non-Hodgkin lymphoma. People who worked with the weed-killer Roundup® across the United States were exposed to glyphosate, which is the main ingredient in the most popular herbicide in the country. Case of DeWayne Johnson against...

July 25, 2018

The FDA issued a safety alert in December 2017, stating that some patients who received a gadolinium-based contrast during an MRI procedure, may retain the gadolinium in their bodies for months, or even for years, causing serious side effects. Gadolinium is commonly used in MRIs to enhance the images the test provides. Gadolinium is a...

July 18, 2018

Valsartan is mainly used for treatment of high blood pressure, congestive heart failure, and after a heart attack. The FDA has announced a recall of several drugs that contain the heart drug valsartan because a possible carcinogen NDMA (N-Nitrosodimethylamine) that was found in the recalled products. NDMA, which was found in the valsartan products, could...

July 17, 2018